Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-inflammatory Agents for Coronary Endothelial Function in CAD
NCT02366091Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Jan 2015
- Primary completion
- Aug 2020
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate, colchicine in coronary artery disease (CAD), sponsored by Johns Hopkins University. Started Jan 2015; status: completed.
02
Drugs
methotrexatecolchicine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02366091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02366091.